FDA 483 - Milupa GmbH - May 26, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Milupa GmbH, an infant formula manufacturer in Fulda, Germany, received a Form 483 with five observations. The inspection revealed significant issues including the reprocessing of microbiologically contaminated infant formula base, inadequate monitoring of critical control points like metal detection, and insufficient testing of nutrient premixes. Additionally, the firm lacked proper temperature control studies for in-process storage and failed to calibrate critical processing instruments.
ID · ae62f52e-4dcc-4d4a-b2d7-ca996dda474b